Your browser doesn't support javascript.
loading
2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationships.
Gleave, Robert J; Beswick, Paul J; Brown, Andrew J; Giblin, Gerard M P; Haslam, Carl P; Livermore, David; Moses, Andrew; Nicholson, Neville H; Page, Lee W; Slingsby, Brian; Swarbrick, Martin E.
Afiliação
  • Gleave RJ; Pain and Neuroexcitability Discovery Performance Unit, Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, United Kingdom. robert.j.gleave@gsk.com
Bioorg Med Chem Lett ; 19(23): 6578-81, 2009 Dec 01.
Article em En | MEDLINE | ID: mdl-19864133
ABSTRACT
2-Amino-5-aryl-pyridines, exemplified by compound 1, had been identified as a synthetically tractable series of CB(2) agonists from a high-throughput screen of the GlaxoSmithKline compound collection. Described herein are the results of an investigation of the structure-activity relationships (SAR) which led to the identification a number of potent and selective agonists.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Receptor CB2 de Canabinoide Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Receptor CB2 de Canabinoide Idioma: En Ano de publicação: 2009 Tipo de documento: Article